A Novel Anti-Thrombotic, Glenzocimab, in Covid-19 acute respiratory distress syndrome (Cov-ARDS).

J Pottecher, V A H Sato, Y Plétan, A Comenducci, V Desort-Henin, M Jandrot-Perrus, S Binay, A Meilhoc, G Avenard
European Respiratory Journal 2022 60: 2878; DOI: 10.1183/13993003.congress-2022.2878

Article Information

vol. 60 no. suppl 66
DOI 
https://doi.org/10.1183/13993003.congress-2022.2878
Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online December 1, 2022.
Copyright & Usage 
Copyright ©the authors 2022

Author Information

  1. J Pottecher1,
  2. V A H Sato2,
  3. Y Plétan3,
  4. A Comenducci3,
  5. V Desort-Henin3,
  6. M Jandrot-Perrus4,
  7. S Binay3,
  8. A Meilhoc3 and
  9. G Avenard3
  1. 1University Hospital, Strasbourg, France
  2. 2Internacional Research Ctr, Hosp. Alemão Oswaldo Cruz, Sau Paulo, Brazil
  3. 3ACTICOR-BIOTECH, Paris, France
  4. 4UMR_S1148 INSERM/Paris U.,, Paris, France

Article usage

Article usage: December 2022 to April 2023

AbstractFullPdf
Dec 20223200
Jan 20231100
Feb 20231700
Mar 20231300
Apr 2023900

Altmetrics

Back to top
Email
Citation Tools

A Novel Anti-Thrombotic, Glenzocimab, in Covid-19 acute respiratory distress syndrome (Cov-ARDS).
J Pottecher, V A H Sato, Y Plétan, A Comenducci, V Desort-Henin, M Jandrot-Perrus, S Binay, A Meilhoc, G Avenard
European Respiratory Journal Sep 2022, 60 (suppl 66) 2878; DOI: 10.1183/13993003.congress-2022.2878
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To